Xiaoqian Deng received her M.D. degree in Clinical Medicine from Xiamen University, Xiamen, China in 2016 and her Ph.D. degree in Ophthalmology from Sun Yat-sen University, Guangzhou, China in 2022. From 2018 to 2019, she is a visiting scholar at the Shiley Eye Institute and the Jacobs School of Engineering at the University of California, San Diego. From 2019 to 2022, she is a visiting scholar at the David Geffen School of Medicine at the University of California, Los Angeles. Her research results have been published in prestigious international journals such as Biomaterials. She is currently working as a postdoctoral fellow at the Zhongshan Ophthalmic Center in Guangzhou, China. Her research interests include single-cell multi-omics sequencing, epigenomics, and stem cell-based regeneration medicine, especially in regulating ocular stem cell proliferation, differentiation, and reprogramming for eye tissue regeneration and treatment of blinding diseases.
Xiaoqian Deng received her M.D. degree in Clinical Medicine from Xiamen University, Xiamen, China in 2016 and her Ph.D. degree in Ophthalmology from Sun Yat-sen University, Guangzhou, China in 2022. From 2018 to 2019, she is a visiting scholar at the Shiley Eye Institute and the Jacobs School of Engineering at the University of California, San Diego. From 2019 to 2022, she is a visiting scholar at the David Geffen School of Medicine at the University of California, Los Angeles. Her research results have been published in prestigious international journals such as Biomaterials. She is currently working as a postdoctoral fellow at the Zhongshan Ophthalmic Center in Guangzhou, China. Her research interests include single-cell multi-omics sequencing, epigenomics, and stem cell-based regeneration medicine, especially in regulating ocular stem cell proliferation, differentiation, and reprogramming for eye tissue regeneration and treatment of blinding diseases.